abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2013년 8월 7일

저자:
Josh Sanburn, Time (USA)

The Hidden Hand Squeezing Texas’ Supply of Execution Drugs [USA]

By September, Texas will run out of the sole drug it uses in lethal injections...In early 2011, Danish drugmaker Lundbeck, which at that time manufactured pentobarbital...discovered that U.S. states were using its product in lethal injections...[Many] in Denmark were upset that medicine made in a country that abolished the death penalty decades ago was being used for ending lives rather than saving them...Amnesty International and U.K.-based Reprieve issued press releases to highlight each new execution that used drugs made by Lundbeck...[Later in 2011] Lundbeck said it would no longer allow the drug to be used in U.S. executions and began reviewing all orders of the drug and denying U.S. prisons looking to order it...Texas...has two executions scheduled in September, two more in October and one in November. [also refers to Hospira, Akorn, Fresenius Kabi (part of Fresenius SE)]